DALLAS--(BUSINESS WIRE)--Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (“AI”) company developing targeted and transformative cancer therapies using its proprietary...
DENVER, Colorado--(BUSINESS WIRE)--Liberty Global Ltd. (“Liberty Global” or the “Company”) (NASDAQ: LBTYA, LBTYB and LBTYK) today announced plans to release...
Geneva, Switzerland, March 20, 2025 (GLOBE NEWSWIRE) -- Schedules Conference Call and Webcast for Monday, March 24 at 10:00 am...
CHICAGO--(BUSINESS WIRE)--Byline Bancorp, Inc. (NYSE: BY) ("Byline" or "the Company") announced that Kroll Bond Rating Agency, LLC (“KBRA”) has upgraded...
Clinical hold lifted for late stage cadisegliatin program for diabetes CATT1 Phase 3 trial in patients with type 1 diabetes...
- Proven financial leader brings decades of experience in capital allocation, business development and shareholder value creation - WALTHAM, Mass.,...
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to...
Toronto, Ontario--(Newsfile Corp. - March 20, 2025) - Denarius Metals Corp. (Cboe CA: DMET) (OTCQX: DNRSF) ("Denarius Metals" or the...
CTIM-76 first patient dosed in January 2025 Cash and cash equivalents of $94.4 million as of December 31, 2024 Company...
CALGARY, Alberta, March 20, 2025 (GLOBE NEWSWIRE) -- Canacol Energy Ltd. (“Canacol” or the “Corporation”) (TSX:CNE; OTCQX:CNNEF; BVC:CNEC) is pleased...
CHICAGO--(BUSINESS WIRE)--Byline Bancorp, Inc. (NYSE: BY) ("Byline" or "the Company") announced that Kroll Bond Rating Agency, LLC (“KBRA”) has upgraded...
Delivered Total and Net Investment Income of $33.8 million and $14.6 million, Respectively Investment Portfolio of $1.1 billion Conference Call...
– Four development candidates in clinical studies with data anticipated this year, continuing rapid progress of antiviral pipeline – –...
LA JOLLA, Calif., March 20, 2025 (GLOBE NEWSWIRE) -- Palomar Holdings, Inc. (NASDAQ:PLMR) (“Palomar” or the “Company”) today announced that...
LOS ANGELES, March 20, 2025 (GLOBE NEWSWIRE) -- PLBY Group, Inc. (Nasdaq: PLBY) (the “Company” or “PLBY Group”), a leading...
GREENWICH, Conn., March 20, 2025 (GLOBE NEWSWIRE) -- Oxford Lane Capital Corp. (NasdaqGS: OXLC) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO)...
DENVER, Colo., 03/20/25 06:00 PM (247marketnews.com) – (NASDAQ: TOMZ, NYSE: EONR, NYSE: ALUR, NASDAQ: PNBK, NYSE: IBO) are discussed in...
CHARLOTTE, N.C., March 20, 2025 /PRNewswire/ -- Nucor Corporation (NYSE: NUE) today announced guidance for its first quarter ending April...
Fully enrolled LORIKEET, a randomized 150-patient Phase 2 study of lorigerlimab in combination with docetaxel in patients with mCRPCInitiating new...
DENVER, Colorado--(BUSINESS WIRE)--Liberty Global Ltd. (“Liberty Global” or the “Company”) (NASDAQ: LBTYA, LBTYB and LBTYK) today announced plans to release...
DENVER, Colo., 20 March, 2025 (247marketnews.com) – (NASDAQ:TOMZ) are discussed in this article. TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) has...
- Reported positive data updates from its ongoing Phase 2a trial of lead program IMM-1-104, including encouraging responses in combination...
Potentially best-in-class RAS-targeting franchise advancing with both ERAS-0015 and ERAS-4001 expected to enter the clinic in 2025 Ongoing Phase 3...
VICTORIA, BC, March 20, 2025 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company...
Dose expansion in Phase 1 CARDINAL trial of TERN-701 for chronic myeloid leukemia (CML) expected to initiate in 2Q25 with...
HOUSTON, March 20, 2025 /PRNewswire/ -- Third Coast Bancshares, Inc. (NASDAQ: TCBX), the holding company of Third Coast Bank, today announced...
WASHINGTON, March 20, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for...
LAS VEGAS--(BUSINESS WIRE)--Cannae Holdings, Inc. (NYSE: CNNE) (“Cannae” or the “Company”) today issued a response to Carronade Capital’s recent statement...
Enrollment completed in Phase 2a CBeyond™ trial of CB1 inhibitor, nimacimab, in obesity and overweightFaster-than-expected enrollment enables full top-line Phase 2a...
A major milestone on March 14th 2025 advanced the EU Trilogue discussions aimed to complete the final text of the...
Advancement of oral, brain-penetrant NLRP3 inhibitor BGE-102, with initial clinical data expected 2H25 Progression of preclinical next-generation APJ agonists for...
HOBOKEN, N.J., March 20, 2025 /PRNewswire/ -- Quantum Computing Inc. ("QCi" or the "Company") (Nasdaq: QUBT), an innovative, integrated photonics and...
Equity recapitalization is expected to result in strong balance sheet and robust capital ratiosPresident Steven Sugarman entered into long-term employment...
Fortified Balance Sheet of $113.0 Million Enables Company to continue R&D activities in AI-Driven Customer Platform in other Corporate Initiatives...
GREENWICH, Conn., March 20, 2025 (GLOBE NEWSWIRE) -- Oxford Lane Capital Corp. (NasdaqGS: OXLC) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO)...
DALLAS, March 20, 2025 /PRNewswire/ -- Ashford Hospitality Trust, Inc. (NYSE: AHT) ("Ashford Trust" or the "Company") announced today that...
BETHESDA, Md., March 20, 2025 /PRNewswire/ -- AGNC Investment Corp. (Nasdaq: AGNC) ("AGNC" or the "Company") announced today that, effective...
DENVER, Colo., 03/20/25 05:00 PM (247marketnews.com) – (NYSE: ALUR, NASDAQ: PNBK, NYSE: IBO, NASDAQ: AEVA, NASDAQ: PEV) are discussed in...
NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- New York Mortgage Trust, Inc. (Nasdaq: NYMT) (the “Company”) announced today that...
SAN FRANCISCO--(BUSINESS WIRE)--Cloudflare, Inc. (NYSE: NET), the leading connectivity cloud company, has been named by Forrester Research, Inc. as a...
